# pimavanserin

NDC: 72205-055
Generic name: pimavanserin
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240116

FDA application: ANDA214925

## Active ingredients

- PIMAVANSERIN TARTRATE: 34 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-055"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-055
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=403b6540-c53d-4e92-91b4-36ca6338b2b1